Global Oncology Imaging AI Market Pulse 2025-2032: Size, Mix & Momentum provides a world-market forecast and segmentation view of AI in oncology imaging across regions, modalities (CT, mammography/DBT, MRI, PET/Nuclear, ultrasound), tumor sites, clinical applications, pathway stages, end-use settings, and revenue streams. The report is designed for corporate strategy, product, commercial, and investment teams who need a clean global sizing reference and a structured view of where growth concentrates.
A key differentiator is the report’s Mix & Momentum framework—pairing 2032 market-size mix (with over/under indexing versus the global benchmark) with dollar-lift growth contribution views. These matrices enable readers to identify “big pools” versus “fast pools,” prioritize the highest-leverage tumor-site and modality intersections, and understand how monetization shifts across software, services, and cloud/usage-based (PPU) models.
Companies Mentioned
- Aidoc
- AIQ Solutions
- Annalise.ai
- Arterys
- Bayer
- Blackford
- Calantic
- Canon Medical
- CARPL.ai
- DeepHealth
- Deepwise
- Densitas
- EXINI Diagnostics
- Fujifilm
- GE HealthCare
- Hermes Medical Solutions
- Hologic
- Imbio
- Incepto
- Kheiron
- Koios Medical
- Lantheus
- Lunit
- Median Technologies
- MIM Software
- Mindray
- Mirada Medical
- MVision AI
- Nuance
- Oxipit
- Perspectum
- Philips
- Ping An Healthcare
- Quibim
- Qure.ai
- Rad AI
- RadNet
- RaySearch
- Riverain
- ScreenPoint
- Sectra
- Segami
- Siemens Healthineers
- Subtle Medical
- Tempus
- TheraPanacea
- United Imaging
- Vara
- Varian

